CAS: 89226-12-0; (S)-2-Amino-N,3,3-Trimethylbutanamide

该化合物是一种在有机合成和制药研究中广泛使用的手动建筑块,其受窒息的抗酸性骨干和N-甲基胺功能可增强异质硬性,使其对peptidemimimictics和不对称催化作用具有价值. 乙基丁基基混合物在保持各种反应条件下的稳定性的同时,提高了有机溶剂的溶解性.该化合物在Peptimimitic,酶抑制剂和生物活性分子的设计中特别有用,因为它能够影响二级结构并抗代谢降解. 它的高对应性纯度和与标准混合试剂的兼容性进一步强调了其在医药化学和药物开发中的效用.

结构式图片

相似化合物

947383-62-2 1867654-07-6 62965-57-5

欧盟法规

C&L通报REACH预注册

上下游产品

CAS号75-36-5 乙酰氯 | CAS号162537-11-3 N-甲氧羰基-L-叔亮氨酸 | CAS号74-89-5 氨基甲烷 | CAS号62965-35-9 N-B°C-L-叔亮氨酸 | CAS号20859-02-3 L-叔亮氨酸 | CAS号178933-95-4 l-valinamide, l...

合成工艺路线路线简述

  • 200865-04-9 = 89226-12-0
    反应条件:1.1 Reagents: Trifluoroacetic Acid Solvents: Dichloromethane; 18 H,0 - 25 °C
    标题:Improved Synthesis Of Adam10 Inhibitor Gi254023X
    作者:Hoettecke,Nicole; Ludwig,Andreas; Foro,Sabine; Schmidt,Boris
    参考文献:Neurodegenerative Diseases 日期:2010 卷标:7(4) 页码:232-238]

    168974-05-8 = 89226-12-0
    反应条件:1.1 Reagents: Ammonia Solvents: Water; Rt
    标题:Synthesis Of New Amino-Functionalized Porphyrins:Preliminary Study Of Their Organophotocatalytic Activity
    作者:Torres,Pol; Guillen,Marian; Escriba,Marc; Crusats,Joaquim; Moyano,Albert
    参考文献:Molecules 日期:2023 卷标:28(4)]

    63038-27-7 = 89226-12-0
    反应条件:1.1 Solvents: Ethanol; 48 H,100 °C1.2 Reagents: Ammonium Hydroxide Solvents: Water; Basified
    标题:Enantioselective α-Alkylation Of Aldehydes By Photoredox Organocatalysis: Rapid Access To Pharmacophore Fragments From β-Cyanoaldehydes
    作者:Welin,Eric R.; Warkentin,Alexander A.; Conrad,Jay C.; Macmillan,David W. C.
    参考文献:Angewandte Chemie 日期:2015 卷标:54(33) 页码:9668-9672]

    1094091-73-2 = 89226-12-0
    反应条件:1.1 Reagents: Trifluoroacetic Acid Solvents: Dichloromethane; 0 °C; 0 °C -> Rt; 3 H,Rt1.2 Reagents: Sodium Hydroxide Solvents: Water; Ph 10,Cooled
    标题:Auxiliary-Controlled Diastereoselective Synthesis Of A Syn C-6-Epimer Of The Adam 10 Inhibitor Gi254023X
    作者:Nair,Shankari; Zeevaart,Jan Rijn; Hunter,Roger
    参考文献:Arkivoc (Gainesville 日期:2020 卷标:(3) 页码:90-102]

    62965-35-9 = 89226-12-0
    反应条件:1.1 Reagents: N-Hydroxysuccinimide Solvents: Methanol,Dimethylformamide; 30 Min,Rt1.2 Rt -> 0 °C1.3 Reagents: 1-Ethyl-3-(3′-Dimethylaminopropyl)Carbodiimide Hydrochloride; 1 H,0 °C; 2 H,Rt1.4 Reagents: Trifluoroacetic Acid Solvents: Dichloromethane; 40 Min,Rt
    标题:Squaric Acid-Based Peptidic Inhibitors Of Matrix Metalloprotease-1
    作者:Onaran,M. Burak; Comeau,Anthony B.; Seto,Christopher T.
    参考文献:Journal Of Organic Chemistry 日期:2005 卷标:70(26) 页码:10792-10802]

    200865-04-9 = 89226-12-0
    反应条件:1.1 Reagents: Trifluoroacetic Acid Solvents: Dichloromethane; 0 °C; 18 H,Rt
    标题:L-Tert-Leucine-Derived Amidphos-Silver(I) Chiral Complexes For The Asymmetric [3+2] Cycloaddition Of Azomethine Ylides
    作者:Zhou,Zhipeng; Zheng,Xiaojun; Liu,Jialin; Li,Jinlei; Wen,Pushan; Et Al
    参考文献:Synlett 日期:2017 卷标:28(8) 页码:999-1003]

    200865-04-9 = 89226-12-0
    反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Dichloromethane,1,4-Dioxane,Water
    标题:N-Hydroxyformamide Peptidomimetics As Tace/matrix Metalloprotease Inhibitors: Oral Activity Via P1' Isobutyl Substitution
    作者:Musso,D. L.; Andersen,M. W.; Andrews,R. C.; Austin,R.; Beaudet,E. J.; Et Al
    参考文献:Bioorganic & Medicinal Chemistry Letters 日期:2001 卷标:11(16) 页码:2147-2151
📜N-Boc-L-叔亮氨酸置于o-(1H-Benzotriazol-1-yl)-N,N,N',N'-Tetramethyluronium Hexafluorophosphate,N,N-二异丙基乙胺,三氟乙酸体系中,用 二氯甲烷 作为反应溶剂,化学反应 18.0H,反应生成 L-叔亮氨酸甲酰胺
参考文献:L-Tert-亮氨酸衍生的amidphos-Silver(I)手性配合物用于azomethine Ylides的不对称[3+2]环加成
标题:L-Tert-亮氨酸衍生的amidphos-Silver(I)手性配合物用于azomethine Ylides的不对称[3+2]环加成
摘要:L-叔亮氨酸衍生的 Amidphos/silver(I) 催化体系已开发用于在有或没有 Et3N 的情况下,偶氮甲碱叶立德与缺电子烯烃的不对称 [3+2] 环加成反应.在最佳条件下,以中等至高产率(高达 99% 的产率)和对映选择性(高达 98% Ee)获得高度官能化的内 4-吡咯烷.
DOI:10.1055/s-0036-1588137

海关参考信息

专利信息


专利号:US-6121487-A
优先权日:1998-07-28
标题 :Method of producing amino acids and amino-acid derivatives
发明人:VOGT ANNEGRET; ALTENBACH HANS-JOSEF; KIRSCHBAUM MICHAEL; HAHN MICHAEL-GOTTFRIED; MATTHAUS MIKE SIEGFRIED PAUL; HERMANN ANDREAS RAINER
权利人:DEGUSSA
摘要:The present invention is relative to a chemical method of producing compounds of the general formula (I) starting from compounds of the general formula (II) and (III) under radical conditions. Products I are used as intermediates in the synthesis of bioactive substances.

专利号:US-6436697-B1
优先权日:1998-10-23
标 题 :Enzyme-mediated synthesis of peptidomimetics
发明人:HOLT KAREN; TAYLOR STEPHEN JOHN CLIFFORD; TIFFIN PETER DAVID
权利人:DARWIN DISCOVERY LTD
摘要:A process for the preparation of a compound of formula (1)comprises reacting compounds of formulae (2) and (3)in the presence of an enzyme, wherein A is a thiol-protecting group, B, C and D are each the same or different organic groups of up to 30 C atoms, optionally functionalized at any position, provided that neither a primary amine nor a primary amide is present, and X is a group that can be displaced by NH2.

专利号:US-5986132-A
优先权日:1995-11-18
标 题 :Synthesis of carboxylic acid derivatives
发明人:REEVE MAXWELL; BOWLES STEPHEN ARTHUR
权利人:BRITISH BIOTECH PHARM
摘要:Compounds of formula (I) wherein R 1 , R 2 , R 3 , R 4 , X are as defined in the specification and are prepared by elimination of one of the groups X 1 and X 2 from a compound of formula (II) wherein X 1 and X 2 each independently represent a carboxylic acid group or salt thereof, or a protected carboxylic acid group, the non-eliminated group X 1 or X 2 corresponding to the group X in the desired compound of formula (I). ##STR1##

专利号:US-5710322-A
优先权日:1996-03-29
标题 :Optically active iminocarboxylic acid derivatives
发明人:BROGER EMIL ALBIN; SCHMID RUDOLF
权利人:HOFFMANN LA ROCHE
摘要:The compounds of the formula ##STR1## wherein R is OH, NH 2 , lower-alkyl-NH or phenyl-lower alkyl-NH are presented. These compounds can be catalytically hydrogenated to the corresponding α-aminocarboxylic acid derivatives which are intermediates in the synthesis of therapeutic pseudopeptides.

专利号:US-6316465-B1
优先权日:1998-06-27
标 题:Ophthalmic uses of PPARgamma agonists and PPARgamma antagonists
发明人:PERSHADSINGH HARRIHAR A; LEVY DANIEL E
权利人:PHOTOGENESIS INC
摘要:Methods of treating diseases of ocular tissues expressing the nuclear receptor PPARgamma, by inhibiting the inflammatory response, the neovascularization and angiogenesis, and programmed cell death (apoptosis) in these target tissues, comprising administering to a human or animal in need of treatment an effective amount of a compound that modifies the activity of PPARgamma, or pharmaceutically acceptable salts and solvates thereof.Novel compounds and methods for their synthesis are provided, including a compound having the general structure:

专利号:WO-0024923-A1
优先权日:1998-10-23
标 题:The enzyme-mediated synthesis of peptidomimetics

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: Luckose F, Et Al. Effects Of Amino Acid Derivatives On Physical, Mental, And Physiological Activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.

合成参考文献


摘要:S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知